is retatrutide glp3 (Reta GLP-3) - 99%+ Purity Retatrutide (GLP-3 (RT)): Research Peptide,

At the maximum 15mg dose, average weight loss reached 22.5%

Participant satisfaction was reported at 94.4 percent

There are now three GLP-1RA drugs approved in multiple countries [see Table 1] for chronic weight management, all of which are administered as injections: Wegovy (active substance semaglutide) and Saxenda (active substance liraglutide) from Novo Nordisk, and Mounjaro/Zepbound 1 (active substance tirzepatide) from Eli Lilly the latter being the first dual receptor agonist 2 drug approved

It works best when paired with strength training and a balanced protein intake

"I would suspect we will have to start notifying customers in the coming month or two that they will need to start looking for alternative options for the commercial dosing," he said

Often yes, temporarily